Glaucoma News

The FDA has accepted a new drug application for PDP-716 for the treatment of glaucoma, according to a press release from Visiox Pharma.

A panel of expert glaucoma surgeons reached consensus on patient selection and preoperative, perioperative and postoperative management with the PreserFlo microshunt drainage device.

The risk for progression from anatomical narrow angle to primary angle closure glaucoma is low and mainly occurs within 6 months of ANA diagnosis, according to a poster presented at Real World Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Osamah Saeedi, MD, discusses the effects of netarsudil on episcleral venous flow in subjects with ocular hypertension and glaucoma suspects.

NEW YORK — In this Healio Video Perspective from OSN New York, Nathan M. Radcliffe, MD, provides an overview of the products and tools in the pipeline for minimally invasive glaucoma surgery.

A second non-implant MIGS intervention, namely canaloplasty and trabeculotomy, allows patients to achieve good IOP control if a prior trabecular micro-bypass stent has failed to maintain IOP as desired.

Patients who present with undiagnosed glaucoma at the emergency room, and are therefore more at risk for glaucoma-related blindness, are more likely to originate from underserved rural areas.

With support from Nova Eye Medical, a group of surgeons has launched a registry that will capture real-world data on canaloplasty procedures performed with the iTrack and iTrack Advance devices.

Smoking intensity was linked with decreased optic nerve vessel density in patients with glaucoma, according to a study in Journal of Glaucoma.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Mitchell C. Shultz, MD, discusses a study that compared the iStent inject W and Hydrus microstent to treat glaucoma in patients who have and have not undergone canaloplasty.